Estefania Labanca, PhD, discusses data on CRPC progression and the use of non-canonical AR signaling and ketone body fuel which were presented at the AACR Annual Meeting.
Yuan Zhang, PhD, and Yi Xiao, PhD, discuss boosting immune surveillance with low-dose PI3K inhibitors to facilitate early intervention of breast cancer.
Xiuning Le, MD, PhD, discusses results from the ZENITH20 trial, which showed that twice daily poziotinib improved AEs and retained anti-tumour activity in EGFR+ or HER2+ NSCLC.
Niamh Coleman, MD, PhD, discusses data on whole exome sequencing (WES) of tumor tissue and ctDNA in GIST, presented at the AACR Annual Meeting.
Nakia Spencer, MSc, discusses the ongoing trial of asparagine synthetase (ASNS) expression to predict patient response to the GLS1 inhibitor IPN60090 in ovarian cancer.
Melissa Davis, PhD, discusses the ongoing research of genomic sequencing in diverse populations, including cancer disparities and ancestries.
Stay in the know.
OncNet Newsletter